77 related articles for article (PubMed ID: 26198315)
1. Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives.
Stanković T; Dankó B; Martins A; Dragoj M; Stojković S; Isaković A; Wang HC; Wu YC; Hunyadi A; Pešić M
Cancer Chemother Pharmacol; 2015 Sep; 76(3):555-65. PubMed ID: 26198315
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters.
Dankó B; Tóth S; Martins A; Vágvölgyi M; Kúsz N; Molnár J; Chang FR; Wu YC; Szakács G; Hunyadi A
ChemMedChem; 2017 Jun; 12(11):850-859. PubMed ID: 28436164
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.
Wartenberg M; Hoffmann E; Schwindt H; Grünheck F; Petros J; Arnold JR; Hescheler J; Sauer H
FEBS Lett; 2005 Aug; 579(20):4541-4549. PubMed ID: 16083877
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Alteration of Reactive Oxygen Species Led to Multidrug Resistance in MCF-7 Cells.
Cen J; Zhang L; Liu F; Zhang F; Ji BS
Oxid Med Cell Longev; 2016; 2016():7053451. PubMed ID: 28058088
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T
Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
[TBL] [Abstract][Full Text] [Related]
8. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide.
Souslova T; Averill-Bates DA
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1538-51. PubMed ID: 15590186
[TBL] [Abstract][Full Text] [Related]
12. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells.
Wang X; Wang C; Zhang L; Li Y; Wang S; Wang J; Yuan C; Niu J; Wang C; Lu G
Anticancer Drugs; 2015 Feb; 26(2):210-23. PubMed ID: 25419632
[TBL] [Abstract][Full Text] [Related]
13. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
[TBL] [Abstract][Full Text] [Related]
14. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle.
Li N; Oberley TD
J Cell Physiol; 1998 Oct; 177(1):148-60. PubMed ID: 9731755
[TBL] [Abstract][Full Text] [Related]
15. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
16. Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells.
Csekes E; Vágvölgyi M; Hunyadi A; Račková L
Life Sci; 2020 Nov; 260():118419. PubMed ID: 32931795
[TBL] [Abstract][Full Text] [Related]
17. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
18. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
[TBL] [Abstract][Full Text] [Related]
19. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
20. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
